SCHEMBL1345453

SCHEMBL1345453

CC(=O)N(CCO)c1ccc(F)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.41
ADORA2B P29275 3/20 0.41
ADORA1 P30542 3/20 0.41
PKM P14618 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TSPO P30536 3/20 0.36
CYP3A4 P08684 1/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
MMP1 P03956 1/20 0.33
MMP7 P09237 1/20 0.33
MMP8 P22894 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1346906 0.81 SSTR4 (0.46) ADORA2AADORA2BADORA1PKMCYP1A2
SCHEMBL5905828 0.81 PKM (0.37) ADORA2AADORA2BADORA1PKMMEN1
SCHEMBL13555062 0.71 ALDH1A1 (0.49) ADORA2AADORA2BADORA1CYP1A2CYP2D6
SCHEMBL1161706 0.70 CA12 (0.39) PKMCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL9359593 0.70 CYP3A4 (0.43) MEN1KMT2ACYP3A4ALDH1A1
SCHEMBL28995170 0.69 TSPO (0.40) NPSR1MEN1KMT2ATSPOCYP3A4
SCHEMBL3635744 0.69 SSTR4 (0.38) PKMMEN1KMT2AALDH1A1LMNA
SCHEMBL3151664 0.69 PHLPP2 (0.37) PKMCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL6453516 0.69 ADORA2A (0.47) ADORA2AADORA2BADORA1MEN1KMT2A
SCHEMBL6451749 0.68 CYP3A4 (0.46) ADORA2AADORA2BADORA1PKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101679395-B Triazolyl aminopyrimidine compounds LILLY CO ELI 2012-06-13 CN disclosed
US-8063035-B2 Triazolyl aminopyrimidine compounds ELI LILLY AND COMPANY (US) 2011-11-22 US disclosed
US-20100087431-A1 TRIAZOLYL AMINOPYRIMIDINE COMPOUNDS ELI LILLY AND COMPANY 2010-04-08 US disclosed
CN-101679395-A triazolyl aminopyrimidine compounds LILLY CO ELI 2010-03-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087431-A1 TRIAZOLYL AMINOPYRIMIDINE COMPOUNDS DPYD, TP53, TYMP ADORA2A 878/4885ADORA2B 1471/4885ADORA1 1994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.